TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Show more

1 Great Valley Parkway, Malvern, PA, 19355, United States

Medical Devices
Healthcare

Market Cap

38.5M

52 Wk Range

$0.50 - $2.20

Previous Close

$0.86

Open

$0.83

Volume

135,726

Day Range

$0.83 - $1.04

Enterprise Value

56.07M

Cash

39.54M

Avg Qtr Burn

-11.17M

Insider Ownership

8.42%

Institutional Own.

68.99%

Qtr Updated

03/31/26


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date